Financing Drug Innovation in the US: Current Framework and Emerging Challenges

The current US drug innovation financing framework rests on the notion that a defined period of marketing exclusivity combined with the expectation of reimbursement for clinically valuable, cost-effective therapies, followed by vigorous price competition from generic drugs and biosimilars ensures a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutler, David, Kirson, Noam, Long, Genia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247916/
https://www.ncbi.nlm.nih.gov/pubmed/32452010
http://dx.doi.org/10.1007/s40273-020-00926-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247916/
https://www.ncbi.nlm.nih.gov/pubmed/32452010
http://dx.doi.org/10.1007/s40273-020-00926-2

Ejemplares similares